Previous Article | Next Article 
Journal of Bacteriology, February 2000, p. 949-955, Vol. 182, No. 4
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cloning, Expression, and Purification of a
Thermostable Nonhomodimeric Restriction Enzyme,
BslI
Pei-chung
Hsieh,
Jian-ping
Xiao,
Diana
O'loane, and
Shuang-yong
Xu*
New England Biolabs, Inc., Beverly,
Massachusetts 01915-5510
Received 21 September 1999/Accepted 12 November 1999
 |
ABSTRACT |
BslI is a thermostable type II restriction endonuclease
with interrupted recognition sequence CCNNNNN/NNGG (/, cleavage
position). The BslI restriction-modification system from
Bacillus species was cloned and expressed in
Escherichia coli. The system is encoded by three genes: the
2,739-bp BslI methylase gene (bslIM), the bslIR
gene, and the bslIR
gene. The
and
subunits of BslI can be expressed independently in
E. coli in the absence of BslI methylase
(M.BslI) protection. BslI endonuclease activity
can be reconstituted in vitro by mixing the two subunits together. Gel
filtration chromatography and native polyacrylamide gel electrophoresis indicated that BslI forms heterodimers (
),
heterotetramers (
2
2), and possibly
oligomers in solution. Two
subunits can be cross-linked by a
chemical cross-linking agent, indicating formation of heterotetramer BslI complex (
2
2). In DNA
mobility shift assays, neither subunit alone can bind DNA. DNA mobility
shift activity was detected after mixing the two subunits together.
Because of the symmetric recognition sequence of the BslI
endonuclease, we propose that its active form is
2
2. M.BslI contains nine
conserved motifs of N-4 cytosine DNA methylases within the
group of
aminomethyltransferase. Synthetic duplex deoxyoligonucleotides
containing cytosine hemimethylated or fully methylated at N-4 in
BslI sites in the first or second cytosine are resistant to
BslI digestion. C-5 methylation of the second cytosine on
both strands within the recognition sequence also renders the site
refractory to BslI digestion. Two putative zinc fingers are
found in the
subunit of BslI endonuclease.
 |
INTRODUCTION |
Type II restriction enzymes are
indispensable tools in creating recombinant DNA molecules. Among the
232 different specificities, nearly half of the
restriction-modification (R-M) systems have been cloned and expressed
(25, 30). Most type II endonucleases, considered to be
homodimers, recognize and cleave within a palindromic DNA sequence
(usually 4 to 8 nucleotides) in reactions that require Mg2+
as a cofactor (7). Among the six type II restriction enzymes that have been analyzed in detail (BamHI [21,
22], BglI [20], Cfr10I
[2], EcoRI [22],
EcoRV [32] and PvuII [1,
3]) all form homodimers in the DNA-protein cocrystal structures.
Another subgroup of restriction enzymes is type IIS (29).
Type IIS enzymes usually cleave 1 to 16 bases downstream of their recognition sequences. However, several R-M systems are found to be
distinct from the conventionally defined type II and type IIS enzymes.
The BcgI-like restriction enzymes cleave double-stranded (ds) DNA on both sides of the recognition sequences in a reaction that
requires S-adenosylmethionine (13).
Eco57I is a single, bifunctional polypeptide with
endonuclease and methylase activities (9). Bpu10I
recognizes an asymmetric sequence and cleaves downstream (CCTNAGC-5/-2)
(28). This enzyme was proposed to belong to the type IIT
subgroup. During the cloning of Bpu10I, it was found that
Bpu10I requires two subunits for its activity. However, the physical association of the two subunits of Bpu10I has not
been demonstrated in vitro.
BslI is a type II restriction endonuclease purified from
Bacillus species with a symmetric recognition sequence
CCN7GG. It cleaves ds DNA to generate a 3-base 3' overhang.
Like BstNI, TfiI, Tsp509I,
TspRI, PspGI, and TliI,
BslI is one of the thermostable restriction enzymes that
remain active after 20 to 30 cycles of thermal cycling. During the
cloning of the BslI R-M system, we found that
BslI requires two proteins for its endonuclease activity. In
this paper, we report the cloning, expression, and purification of the
two subunits and the subunit organization of BslI
endonuclease. We also investigated the effect of N-4 and C-5 cytosine
modifications of the BslI site against BslI
digestion. To our knowledge, this is the first report of a
nonhomodimeric restriction enzyme that recognizes a symmetric DNA sequence.
 |
MATERIALS AND METHODS |
Materials.
Cross-linking reagent
3,3'-dithiobis(sulfosuccinimidylpropionate) (DTSSP) was purchased from
Pierce, Inc. (Rockford, Ill.). T7 expression host ER2566 was
constructed and provided by E. Raleigh (unpublished data; New England
Biolabs [NEB], Beverly, Mass.). The IMPACT I protein purification kit
and molecular biology reagents were from NEB. The 10- to 100-bp DNA
marker was purchased from Life Technologies (Gaithersburg, Md.).
Sephacryl S-100 HR, heparin Sepharose, and DEAE Sepharose resins were
from Pharmacia Biotech Inc. (Piscataway, N.J.). The
BslI-producing strain of a Bacillus species was
originally isolated by D. Cowan and J. Ward (Department of Biochemistry
and Molecular Biology, University College London, London, United
Kingdom). This strain is available from NEB's collection (D. Cowan, J. Ward, J. J. Pelletier, and R. Morgan, unpublished result).
Methods. (i) Assay of BslI endonuclease
activity.
Native and recombinant BslI enzymatic
activities were assayed at 55°C in 30 µl of NEB buffer 3 (100 mM
NaCl, 50 mM Tris-HCl [pH 7.9], 10 mM MgCl2, 1 mM
dithiothreitol [DTT]). One unit of BslI activity is
defined as the amount of enzyme for complete digestion of 1 µg of
pUC19 DNA at 55°C in 1 h.
(ii) Purification of native BslI and N-terminal amino
acid sequencing.
Native BslI restriction enzyme was
purified by chromatography through phosphocellulose P11 (Whatman,
Maidstone, United Kingdom), heparin-Sepharose, DEAE-Sepharose, and
Affi-Gel blue (Bio-Rad Laboratories) columns. The peak fractions of
BslI restriction activity were pooled. The purified native
BslI was subjected to electrophoresis and electroblotted
according to published procedures (14, 17). The membrane was
stained with Coomassie blue R-250, and the protein bands of
approximately 36 and 26 kDa were excised and subjected to sequential
degradation on an Applied Biosystems model 407A protein sequencer.
(iii) Cloning and DNA sequencing.
The construction of a
Sau3AI partial genomic DNA library and selection of the
BslI methylase clone were performed as previously described
(11). The insert containing the methylase gene was sequenced
using the dye terminator sequencing kit from PE Biosystems. The
BslI endonuclease gene sequence was derived by inverse PCR amplification of the sequence adjacent to the methylase gene.
(iv) Expression of BslI methylase gene in
Escherichia coli.
The entire BslI methylase gene
(bslIM) was amplified from genomic DNA using Vent DNA
polymerase and cloned into pBR322 and pACYC184 to generate pBR322-BslIM
and pACYC184-BslIM. T7 expression host ER2566 [pACYC184-BslIM] was
used for BslI expression.
(v) Expression of bslIR
, bslIR
, and
bslIR
in T7 expression vector pAII17.
Expression
vector pAII17 is a modified pET11 vector that contains four copies of
transcription terminators upstream of the T7 promoter (12).
DNA containing bslIR
, bslIR
, and
bslIR
genes was amplified by PCR. The PCR-amplified
products were digested with NdeI and BamHI and
cloned into expression vector pAII17. The recipient host was ER2566
[pACYC184-BslIM]. Cell extracts containing BslI
,
BslI
, and BslI
were prepared as
described previously (33).
(vi) Expression of BslI
and BslI
as
fusion proteins to intein and CBD.
The bslIR
gene
was amplified by PCR and cloned into the NdeI and
SmaI sites of plasmid pTYB2 (NEB's product) to generate pTYB2-BslI
. The resulting plasmid encoded a fusion
protein consisting of the BslI
subunit, intein, and the
chitin binding domain (CBD). The fusion of CBD allows one-step affinity
purification through chitin columns. One extra Gly residue was added at
the C terminus of the
subunit (BslI
) to increase the
yield of the BslI
subunit-intein-CBD fusion protein.
The bslIR
gene was amplified by PCR and cloned into
NdeI and SapI sites of plasmid pTYB1 (NEB's
product) to yield pTYB1-BslI
. For protein overexpression,
cells were first cultured at 37°C to late log phase. Following IPTG
(isopropyl-
-D-thiogalactopyranoside) induction, cells
were incubated at 16°C overnight. The lower temperature reduced the
in vivo cleavage of the fusion protein. Construction of gene fusion
plasmids allowed purification of BslI
and
BslI
subunits separately using the IMPACT I affinity
purification system.
(vii) Purification of recombinant BslI
and
BslI
subunits and bslI
complex.
To purify
and
subunits, cell extracts containing
BslI
-intein-CBD or BslI
-intein-CBD fusion
proteins were passed through a chitin column and washed with 10 bed
volumes of column buffer containing 20 mM Tris-HCl (pH 7), 500 mM NaCl,
0.1 mM EDTA, and 0.1% Triton X-100 (4). The chitin column
was then incubated with column buffer containing 40 mM DTT overnight at
4°C to induce the cleavage between the
(or
) subunit and
intein-CBD. The
subunit elutant from the chitin column was further
loaded onto a heparin-Sepharose column and washed with 10 bed volumes
of 50 mM potassium phosphate buffer (pH 7.5) containing 100 mM NaCl. The pure
subunit protein was identified in the unbound fractions. The
subunit was purified to homogeneity by a one-step chitin column.
To purify the
BslI


complex, cell extracts containing
the
BslI

-intein-CBD fusion protein and the
BslI

protein were mixed
and passed through a chitin
column. The conditions for washing
the column and elution were the same
as those described above.
To remove the potential excess amount of the

subunit, the elutants
from the chitin column were loaded onto a
heparin Sepharose column.
The


complex of
BslI bound
to the column and was coeluted at
about 500 mM NaCl using a linear NaCl
gradient from 100 mM to
1
M.
(viii) Cross-linking reactions.
Cross-linking of proteins
was carried out according to the manufacturer's protocol. The
concentration of protein in the reaction mixture was 6 mg/ml in 20 mM
potassium phosphate (pH 7.5)-100 mM NaCl. The cross-linking reagent
DTSSP was added to the protein sample with a 20-fold molar excess over
the protein. The cross-linking reaction was carried out for 1 h on
ice and was quenched by the addition of an excess amount of glycine. To
identify the cross-linking complex after DTSSP treatment, the sample
was separated on a nonreducing sodium dodecyl sulfate-10%
polyacrylamide gel electrophoresis (SDS-10% PAGE) gel in the first
dimension and a reducing SDS-10% PAGE gel in the second dimension
(10).
(ix) Methylation protection assay.
As shown in Table
1, 10 BslI-containing
deoxyoligonucleotides with or without methylated cytosines were
synthesized. Different combinations of deoxyoligonucleotides listed in
Table 1 were prepared, incubated at 80°C for 5 min, and then
gradually cooled to room temperature. Formation of deoxyoligonucleotide
duplexes was examined on 4% agarose gels.
(x) PAGE.
SDS-PAGE was carried out in a 10 to 20% slab gel
by the method of Laemmli. Proteins were visualized by staining with
Coomassie blue R-250. Native PAGE was carried out at pH 8.8 using 10 to 20% gradient polyacrylamide gels purchased from Novex Inc.
(xi) DNA mobility shift assay.
A 359-bp
HindIII-AflIII fragment from pUC19
(nucleotides 447 to 806) was gel purified and end labeled by filling in
with [33P]dCTP and [33P]dGTP. This fragment
contains a single BslI site. A DNA binding assay was carried
out as previously described (8, 33). The DNA binding buffer
contained 100 mM NaCl, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 10 mM
-mercaptoethanol, and 10 µg of herring sperm DNA/ml. DNA (85 ng)
was incubated with 1 µl of diluted cell extract or purified
BslI protein for 20 min at room temperature in 1× DNA
binding buffer. Following the addition of 2 µl of 50% glycerol, the
DNA-protein complex was resolved in a 6% native polyacrylamide gel
which had been prerun in 0.5× Tris-borate-EDTA buffer. An autoradiogram was obtained after overnight exposure.
Nucleotide sequence accession number.
The R-M gene sequence
has been assigned GenBank accession no. AF135191.
 |
RESULTS |
Cloning of the BslI R-M system in E. coli.
A
partially resistant clone was found in a Sau3AI partial
genomic DNA library after methylase selection. The entire insert of
3,063 bp was sequenced. Translation of the DNA sequence indicated that
the cloned methylase lacked a start codon; therefore, inverse PCR was
employed to amplify the upstream DNA. An additional 17 codons were
found upstream. The 2,739-bp open reading frame (ORF) codes for a
protein of 912 amino acids (aa) with predicted molecular mass of 105 kDa. The gene was amplified by PCR and cloned in pBR322 and pACYC184.
Plasmids carrying the methylase gene are resistant to BslI
digestion, indicating good expression and BslI site
modifications. An amino acid sequence comparison of M.BslI
with other cytosine methylases indicated that all the conserved N-4
cytosine methylase motifs were located in the C terminus of the protein
(Fig. 1; aa residues 674 to 898)
(15, 31). M.BslI belongs to the
group of
aminomethyltransferases (15, 31). The N terminus of
M.BslI was also required for its activity, since deletion of this region abolished methylase activity (data not shown). The N
terminus was not part of the BslI endonuclease, because
BslI endonuclease activity was encoded by two genes
downstream (see below).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Gene organization of BslI R-M system. Nine
conserved motifs of M.BslI were defined according to N-4
cytosine methyltransferase (15). The amino acid residues of
each motif are in parentheses. The BslIR and
bslIR genes are located downstream of the
bslIM gene.
|
|
Analysis of BslI sites with methylated cytosine against
BslI digestion.
To study the effects of cytosine
modification on BslI digestion, 25 sets of
deoxyoligonucleotide duplexes (Table 1) were incubated with
BslI endonuclease overnight. Figure
2 shows that deoxyoligonucleotide
duplexes were refractory to BslI digestion when
BslI sites were N-4-C hemimethylated (lanes 2, 3, 6, and 11)
or N-4-C fully methylated in the first or second cytosine (lanes 7, 8, 12, and 13). Interestingly, when the second cytosine was methylated in
the C-5 position on both strands, the duplex was also resistant to
BslI, which was a case of noncognate methylation protection
(lane 23). Partial protection against BslI digestion was
observed when the second cytosine on one strand of DNA was methylated
at C-5 (lanes 5 and 20). BslI sites with N-4 and C-5 methylations were also resistant to BslI digestion (lanes 9, 10, 14, 15, 17, 18, 21, and 22). Duplexes without methylation (lane 1)
or with the first cytosine methylated at C-5 (lanes 4, 16, and 19) did
not confer any protection against BslI digestion, as
evidenced by the disappearance of the substrate band. The results are
summarized on the top panel of Fig. 2. In a control experiment, duplex
formation before BslI digestion was confirmed on a 4%
agarose gel (data not shown).

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 2.
Duplex deoxyoligonucleotides challenged with
BslI endonuclease. M, 10-bp DNA marker. The arrowhead
indicates the migration of uncleaved substrates. The recognition
sequence of BslI is CCN7GG. (C1,4)
and (C2,4), first and second cytosines, respectively,
methylated at the N-4 position; (C1,5) and
(C2,5), first and second cytosines, respectively,
methylated at the C-5 position. Blank cells indicate no DNA
methylation.
|
|
Cloning and expression of BslI
, BslI
,
and BslI
.
As R-M genes are located in close
proximity to each other, efforts are made to clone the DNA sequence
flanking the methylase gene. After three rounds of inverse PCR, one
partial RadC gene homolog was found upstream and two ORFs were found
downstream. Expression of each ORF alone in E. coli did not
yield any BslI activity (data not shown). In order to obtain
the N terminus amino acid sequence of the native BslI,
native BslI was purified to near homogeneity. Two major
bands of approximately 26 and 36 kDa were found in the peak fractions.
The N-terminal sequences of the ~26- and ~36-kDa bands match
closely with the amino acid sequences predicted from the DNA sequences
of ORF1 and ORF2 (data not shown). When two ORFs were expressed in
M.BslI-premodified E. coli, BslI activity was detected in the cell extract (data not shown). Thus ORF1
and ORF2 were named bslIR
and bslIR
, coding
for the
and
subunits, respectively, of BslI
endonuclease. The predicted molecular masses of the
and
subunits are 25,604 and 35,272 Da, respectively, which are in close
agreement with the molecular weights estimated from the SDS-PAGE. The
genes bslIR
and bslIR
were also expressed
in the T7 expression vector separately in the absence of
M.BslI methylase protection. BslI endonuclease activity was reconstituted by mixing the cell extracts of
and
subunits (see below).
To investigate the DNA binding activity of the

and

subunits,
cell extracts containing the

or

subunit were used in
a DNA
mobility shift assay. The

or

subunit alone did not cause
a band
shift (Fig.
3, lanes 3 to 6). When cell
extracts containing

and

subunits were mixed together in vitro
and then used for
DNA binding, a shifted band was detected (Fig.
3,
lanes 7 and
8). When cell extracts of

and

subunits coexpressed
in the
same host were used in the binding assay, a shifted band was
also
detected (Fig.
3, lanes 9 and 10). A positive signal was detected
using the purified recombinant
BslI restriction enzyme (Fig.
3,
lane 11). It was concluded that both

and

subunits are
required
for efficient binding to DNA.

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 3.
DNA binding assay. Lanes 1 and 2, DNA incubated with
cell extracts; lanes 3 and 4, DNA incubated with cell extracts
containing the subunit; lanes 5 and 6, DNA incubated with cell
extracts containing the subunit; lanes 7 and 8, DNA incubated with
cell extracts containing the and subunits mixed together in
vitro; lanes 9 and 10, DNA incubated with cell extracts containing the
and subunits coexpressed in vivo; lane 11, purified
BslI restriction enzyme (25 U); lane 12, DNA substrate.
Lanes 1, 3, 5, 7, and 9, cell extracts diluted by one-third; lanes 2, 4, 6, 8, and 10, cell extracts diluted by one-ninth. The arrow
indicates the migration of the DNA-protein complex.
|
|
To facilitate purification of
BslI endonuclease, the

subunit was expressed as a fusion to intein and CBD. The

subunit
was expressed in
E. coli independently. Cell extracts
containing
the

-intein-CBD fusion protein and

subunit were
prepared separately
and mixed together in vitro. The
BslI
endonuclease (


complex)
was copurified on the chitin column
following intein cleavage
by DTT treatment (data not shown). The
specific activity of the
purified
BslI enzyme was
10
5 U/mg of protein. It was concluded that the

subunit
can form
a tight complex with the

-intein-CBD fusion protein and
that
it can be copurified via an affinity purification
column.
To purify an individual subunit, the
bslIR
gene was
cloned into the IMPACT I vector pTYB1 and expressed in
E. coli as a fusion
protein. The

subunit was purified to
homogeneity from cell extracts
of ER2566 [pACYC184-
BslIM,
pTYB1-
BslI

] using a chitin column
(data not shown). The

subunit was purified to homogeneity from
cell extracts of ER2566
[pACYC184-BslIM, pTYB2-BslI

] using chitin
affinity purification
and a heparin-Sepharose column (data not
shown).
Figure
4 shows that purified

and

subunits alone did not display ds DNA cleavage activity (lanes 2 and
3). When

and
subunits were premixed in the same cleavage
reaction mixture,
pUC19 DNA was digested completely (lane 4). The
purified
BslI
from coexpressed cell extract also gave rise
to complete digestion
(lane 5). It was concluded that

and

subunits can be expressed
and purified independently and that
BslI activity can be reconstituted
in vitro by mixing the
two subunits.

View larger version (116K):
[in this window]
[in a new window]
|
FIG. 4.
DNA cleavage assay. Lane 1, 1-kb DNA marker (NEB), lanes
2 and 3, pUC19 DNA digested with purified and subunits,
respectively; lane 4, pUC19 DNA digested with reconstituted
BslI (purified and subunits mixed); lane 5, pUC19
DNA digested with BslI purified from coexpressed cell
extract; lane 6, undigested pUC19.
|
|
The specific activity of the reconstituted
BslI is
10
4 U/mg of protein. Perhaps mixing the purified

and

subunits in vitro
did not cause all subunits to form the active
species so that
the specific activity was lower than that of the
copurified

complex.
Composition and stoichiometry analysis of BslI
endonuclease.
To study the oligomeric nature of BslI
endonuclease, the individually purified
and
subunits and the
reconstituted complex were analyzed by native PAGE. Figure
5A shows that the
subunit migrated
into the lower portion of the native gel and exhibited doublet bands
after Coomassie staining (lane 1). A doublet band in lane 1 could be
due to different oxidation states (because many Cys residues are
present in the
subunit, the number of disulfide bonds may result in
different conformations). The doublet was not a contaminant since a
single band of the
subunit was detected by SDS-PAGE of the same
BslI
subunit preparation (data not shown). The
BslI
subunit remained in the well and failed to migrate
into the gel, probably due to oligomerization or aggregation and the
net negative surface charge of the protein (Fig. 5A, lane 2). When
purified
and
subunits were mixed together, a reconstituted 
complex was detected (Fig. 5A, lane 3). Furthermore, when two subunits were copurified from a chitin column by mixing cell extracts containing the
-intein-CBD fusion protein and the
subunit, multiple BslI complex formations were detected by native
PAGE (Fig. 5A, lane 4). To further analyze the subunit organization, the gel slice containing all protein complexes was loaded onto a
second-dimension SDS-PAGE gel (from left to right in Fig. 5B are
resolved complexes with decreasing molecular weights). Figure 5B shows
that the lower band found in the native gel of Fig. 5A, lane 4, was
resolved into two bands (
and
) by SDS-PAGE (right). The upper
band in native gel was also separated into two bands by SDS-PAGE
(middle). The remaining large oligomers seem to contain more
subunit than
(left). To determine the native molecular weight and
stoichiometry, the copurified BslI endonuclease was subjected to chromatography on a Sephacryl S-100 HR gel filtration column. Two peaks containing BslI restriction activity
fractionated with elution volumes of 41 and 37 ml, corresponding to
calculated molecular masses of 76 kDa and greater than 100 kDa,
respectively (data not shown). The calculated molecular mass for one
subunit associated with one
subunit was 60 kDa. To estimate the
higher molecular mass of the BslI complex, the purified
BslI enzyme was loaded onto a Superose 12 column. Two peaks
with BslI activity, migrating between bovine gamma globulin
(150 kDa) and ovalbumin (44 kDa), were identified, which is consistent
with complexes of
2
2 (120 kDa) and
1
1 (60 kDa).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 5.
Native PAGE and SDS-PAGE analysis of individual and
subunits and  complexes. (A) In vitro reconstitution of and subunits of BslI endonuclease. Lane 1, 5 µg of
purified BslI subunit; lane 2, 5 µg of purified
BslI subunit; lane 3, 5 µg of purified
BslI subunit and 5 µg of purified BslI
subunit mixed at 4°C overnight prior to gel electrophoresis; proteins
were resolved by native 10 to 20% PAGE; lane 4, copurified
BslI endonuclease (6 mg/ml) resolved in a native 10 to 20%
gradient gel with longer running time. (B) Two-dimensional gel
electrophoresis analysis. The entire contents of lane 4 of panel A were
excised and loaded onto an SDS-10% PAGE gel in the second dimension
(from left to right are resolved complexes with decreasing molecular
weights). M, molecular mass standard. Arrows indicate and subunits.
|
|
Two-dimensional PAGE analysis of the cross-linking complex of
BslI endonuclease.
As described above, some
BslI endonuclease was present in the form of tetramer
2
2. To investigate the potential
interactions among these subunits, we used the chemical reagent DTSSP
to cross-link the BslI subunits. This cross-linker targets
primary amine groups and is cleavable by thiol. Figure
6A shows a cross-linked complex migrating
at 60 kDa on a nonreducing SDS-PAGE gel (lane 2). This cross-linked
complex was dissociated in the presence of 5%
-mercaptoethanol (Fig. 6A, lane 3). In order to confirm the composition of this complex,
a second-dimension SDS-PAGE was performed followed by silver or
Coomassie blue stainings. Figure 6B shows that the cross-linked complex
was reversed to a 35-kDa protein, indicating that the
subunit is
the only component of the cross-linked 60-kDa complex. It was concluded
that BslI endonuclease forms a heterotetramer through close
-
subunit interactions.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 6.
Identification of a cross-linked product of
BslI complex in vitro. (A) First-dimension SDS-PAGE.
DTSSP-treated BslI endonuclease was subjected to
electrophoresis in the presence and absence of -mercaptoethanol on a
nonreducing SDS-10% PAGE gel. Lane M, molecular mass standards; lane
1, BslI endonuclease without DTSSP treatment; lane 2, BslI endonuclease treated with DTSSP; lane 3, BslI endonuclease treated with DTSSP followed by incubation
in 5% -mercaptoethanol for 1 h at 37°C. (B) Second-dimension
SDS-PAGE. The entire contents of lane 2 of the first-dimension gel were
excised and incubated in Laemmli buffer containing 5%
-mercaptoethanol at 37°C for 15 min. The sliced gel was then
loaded into a reducing SDS-10% PAGE gel. Lane M, molecular mass
standard. BslI and - subunits are indicated by
arrows.
|
|
 |
DISCUSSION |
In this report, we describe the cloning and expression of three
genes in the BslI R-M system from Bacillus
species. Amino acid sequence comparison with other methylases indicates
that M.BslI belongs to the
group of
aminomethyltransferases. BslI endonuclease activity requires
and
subunits, which can be expressed independently in the
absence of methylase protection, and BslI activity can be
reconstituted in vitro by mixing the two purified subunits. Native
PAGE, SDS-PAGE, gel filtration, and chemical cross-linking indicate
that BslI forms heterodimers and heterotetramers. Intimate
-
subunit interactions are detected in the tetramer and oligomer
formation. Based on the symmetry of the tetramer and the palindromic
DNA recognition sequence CCN7GG, we propose that the active
form of BslI is a tetramer. This is the first discovery of a
nonhomodimeric type II restriction enzyme that cleaves a symmetric DNA sequence.
BslI methylase.
The C-terminal region (aa residues
650 to 927) of M.BslI exhibits 20 to 30% amino acid
sequence identity to some known N-4 cytosine methylases. Nine conserved
motifs can be identified in the C-terminal part of M.BslI
(aa residues 674 to 898). M.BslI belongs to the
group of
the aminomethylases. The nature of BslI site modification by
M.BslI in vivo remains to be determined. The exact role of
the N-terminal region of M.BslI is not clear. Nevertheless,
this region is required for methylase activity because deletion of 17 aa residues from the N terminus resulted in a decrease in methylase
activity (partial modification). A larger deletion from the N terminus
also abolished methylase activity. Recently, Sethmann et al. reported
that a target-recognizing domain for the HaeII specificity
is located at the N terminus in the multispecific C-5 methylase
M.(
)BssHII (27). We have not exhaustively
tested other sites that BslI may modify in vivo or in vitro.
BslI endonuclease.
By native PAGE and gel
filtration we demonstrated that BslI endonuclease exists as
heterodimers, heterotetramers, and possibly oligomers in solution.
Chemical cross-linking of BslI indicates close interactions
between
-
subunits, which may be required for tetramerization.
The abnormal migration of a
-
cross-linked complex on the
nonreducing SDS-PAGE gel may be due to intramolecular cross-linking,
which may prevent the protein from complete denaturation, and thus the
protein may retain some secondary structure. The presence of local
nondenaturing structures may cause migration on the nonreducing
SDS-PAGE gel faster than that of molecular weight standards.
Nevertheless, the reducing second-dimension SDS-PAGE clearly indicates
that the cross-linked product was resolved into the size of the
subunit. For a nonhomodimeric enzyme to recognize and cleave a
palindromic sequence (CCN7GG), the formation of tetramers
is apparently a good approach to solve the symmetry problem. In
addition to tetramer formation in solution, it is possible that a
tetramer may be formed on DNA when two sliding heterodimers meet at the
BslI site and then cleave DNA.
The advantage of working with a nonhomodimeric restriction enzyme as a
model system is that either subunit can be expressed
in the absence of
methylase protection as demonstrated in this
work. This unique property
may be a useful tool for creation of
new enzyme
specificity.
Putative zinc finger motifs in the
subunit.
The
subunit contains two putative zinc fingers located at amino acid
residues 36 to 84 (Table 2). This region
shows homology to other known zinc finger proteins, such as KRAB
(5), HZP-126 (26), MZFP-37 (19), MZFP
s11-6, and PLZF. The Cys residues shown in boldface in Table 2 are
candidates involved in zinc binding. This is the first observation that
a restriction enzyme contains putative zinc finger motifs. Most of the
zinc finger motifs are present in eucaryotic transcriptional factors
(23). The general zinc finger motif is
CX4CX10-12HX4H, where X is any
amino acid residue. Sequence specific recognition is modulated by the
amino acid residues between Cys and His. The zinc ion is coordinated
among two cysteines and two histidines, which, in some cases, are
replaced by cysteines (18, 24). Intron-encoded homing
endonuclease I-PpoI was also found to bind the zinc ion (6). By analogy to I-PpoI, the BslI
subunit may require zinc for protein structural folding.
A single amino acid replacement of Cys
53 by Arg (C53R) in
the

subunit resulted in the loss of the
BslI enzymatic
activity
(P. Hsieh and S. Xu, unpublished data). This preliminary
result
suggests the importance of Cys
53 in the region of
the putative
zinc fingers. Further site-directed mutagenesis and
structural
studies are needed to elucidate the roles of the putative
zinc
fingers.
DNA sequence upstream of the BslI R-M system.
A
partial ORF of 357 bp was found upstream of the bslIM gene.
The predicted amino acid sequence encoded by this partial ORF shows
71% similarity (52% identity) to OrfB, a RadC homolog, of Bacillus subtilis. In B. subtilis, the genes
downstream of orfB are mreB, mreC, and
mreD, which are not R-M genes (16).
Expression of BslI
-intein-CBD and
BslI
-intein-CBD.
The expression level of the fusion
proteins was low when fusion protein production was induced by the
addition of IPTG and reaction mixtures were incubated at 37°C. This
was due to the in vivo cleavage between BslI
and
intein-CBD (or between BslI
and intein-CBD). The problem
of in vivo cleavage between BslI
and intein-CBD can be
reduced by incubating the cells at 16°C overnight following IPTG
induction and by the addition of a Gly residue at the C terminus of the
subunit. By using chitin columns and intein cleavage after fusion
protein binding, the individual
and
subunits can be easily
purified. The cloning, expression, and purification of BslI
provide a foundation for structural studies of the protein and make
possible the engineering of new specificities.
 |
ACKNOWLEDGMENTS |
We thank William Jack, Richard Roberts, and Ira Schildkraut for
discussion and critical comments; Jack Benner for protein sequencing;
Michael Dalton for assistance with gel filtration chromatography; Mehul
Ganatra, Laurie Mazzola, Jennifer Ware, and Barton Slatko for DNA
sequencing; and Donald Comb for support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: New England
Biolabs, Inc., 32 Tozer Rd., Beverly, MA 01915-5510. Phone: (978)
927-5054. Fax: (978) 927-1350. E-mail: xus{at}neb.com.
 |
REFERENCES |
| 1.
|
Athanasiadis, A.,
M. Blassi,
D. Kotsifaki,
P. A. Tucker,
K. S. Wilson, and M. Kokkinidis.
1994.
Crystal structure of PvuII endonuclease reveals extensive structural homologies to EcoRV.
Nat. Struct. Biol.
1:469-475[CrossRef][Medline].
|
| 2.
|
Bozic, D.,
S. Grazulis,
V. Siksnys, and R. Huber.
1996.
Crystal structure of Citrobacter freundii restriction endonuclease Cfr10I at 2.15 Å resolution.
J. Mol. Biol.
255:176-186[CrossRef][Medline].
|
| 3.
|
Cheng, X.,
K. Balendiran,
I. Schildkraut, and J. E. Anderson.
1994.
Structure of PuvII endonuclease with cognate DNA.
EMBO J.
13:3927-3935[Medline].
|
| 4.
|
Chong, S.,
F. B. Mersha,
D. G. Comb,
M. E. Scott,
D. Landry,
L. M. Vence,
F. B. Perler,
J. Benner,
R. B. Kucera, and C. A. Hirvonen.
1997.
Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element.
Gene
192:271-281[CrossRef][Medline].
|
| 5.
|
Dreyer, S. D.,
L. Zhou,
M. A. Machado,
W. A. Horton,
B. Zabel,
A. Winterpacht, and B. Lee.
1998.
Cloning, characterization and chromosomal assignment of the human ortholog of murine Zfp-37, a candidate gene for Nager syndrome.
Mamm. Genome
9:458-462[CrossRef][Medline].
|
| 6.
|
Flick, K. E.,
M. S. Jurica,
R. J. Monnat, Jr., and B. L. Stoddard.
1998.
DNA binding and cleavage by the nuclear intron-encoded homing endonuclease I-PpoI.
Nature
394:96-101[CrossRef][Medline].
|
| 7.
|
Heitman, J.
1993.
On the origins, structures and functions of restriction-modification enzymes.
Genet. Eng. (N.Y.)
15:57-108.
|
| 8.
|
Holtz, J. K., and M. D. Topal.
1994.
Location of putative binding and catalytic sites of NaeI by random mutagenesis.
J. Biol. Chem.
269:27286-27290[Abstract/Free Full Text].
|
| 9.
|
Janulaitis, A.,
R. Vaisvila,
A. Timinskas,
S. Klimasauskas, and V. Butkus.
1992.
Cloning and sequence analysis of the genes coding for Eco57I type IV restriction-modification enzymes.
Nucleic Acids Res.
20:6051-6056[Abstract/Free Full Text].
|
| 10.
|
Joshi, S., and R. Burrows.
1990.
ATP synthase complex from bovine heart mitochondria.
J. Biol. Chem.
265:14518-14525[Abstract/Free Full Text].
|
| 11.
|
Kiss, A., and F. Baldauf.
1983.
Molecular cloning and expression in Escherichia coli of two modification methylase genes of Bacillus subtilis.
Gene
21:111-119[CrossRef][Medline].
|
| 12.
|
Kong, H.,
R. B. Kucera, and W. E. Jack.
1993.
Characterization of a DNA polymerase from the hyperthermophile archaea Thermococcus litoralis.
J. Biol. Chem.
268:1965-1975[Abstract/Free Full Text].
|
| 13.
|
Kong, H., and C. L. Smith.
1997.
Substrate DNA and cofactor regulate the activities of a multi-functional restriction-modification enzyme, BcgI.
Nucleic Acids Res.
25:3687-3692[Abstract/Free Full Text].
|
| 14.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 15.
|
Malone, T.,
R. M. Blumenthal, and X. Cheng.
1995.
Structure-guided analysis reveals nine sequence motifs conserved among DNA amino-methyltransferases, and suggests a catalytic mechanism for these enzymes.
J. Mol. Biol.
253:618-632[CrossRef][Medline].
|
| 16.
|
Margolis, P. S.,
A. Driks, and R. Losick.
1993.
Sporulation gene spoIIB from Bacillus subtilis.
J. Bacteriol.
175:528-540[Abstract/Free Full Text].
|
| 17.
|
Matsudaira, P.
1987.
Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.
J. Biol. Chem.
262:10035-10038[Abstract/Free Full Text].
|
| 18.
|
Morohoshi, F.,
Y. Ootsuka,
K. Arai,
H. Ichikawa,
S. Mitani,
N. Munakata, and M. Ohki.
1998.
Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.
Gene
221:191-198[CrossRef][Medline].
|
| 19.
|
Nelki, D.,
K. Dudley,
P. Cunningham, and M. Akhavan.
1990.
Cloning and sequencing of a zinc finger cDNA expressed in mouse testis.
Nucleic Acids Res.
18:3655[Free Full Text].
|
| 20.
|
Newman, M.,
K. Lunnen,
G. Wilson,
J. Greci,
I. Schildkraut, and S. E. V. Phillips.
1998.
Crystal structure of restriction endonuclease BglI bound to its interrupted DNA recognition sequence.
EMBO J.
17:5466-5476[CrossRef][Medline].
|
| 21.
|
Newman, M.,
T. Strzelecka,
L. F. Dorner,
I. Schildkraut, and A. K. Aggarwal.
1995.
Structure of BamHI endonuclease bound to DNA: partial folding and unfolding on DNA binding.
Science
269:656-663[Abstract/Free Full Text].
|
| 22.
|
Newman, M.,
T. Strzelecka,
L. F. Dorner,
I. Schildkraut, and A. K. Aggarwal.
1994.
Structure of restriction endonuclease BamHI and its relationship to EcoRI.
Nature
368:660-664[CrossRef][Medline].
|
| 23.
|
Pavletich, N. P., and C. O. Pabo.
1991.
Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 Å.
Science
252:809-817[Abstract/Free Full Text].
|
| 24.
|
Pountney, D. L.,
R. P. Tiwari, and J. B. Egan.
1997.
Metal and DNA binding properties and mutational analysis of the transcription activating factor of coliphage 186: a prokaryotic C4 zinc-finger protein.
Protein Sci.
6:892-902[Medline].
|
| 25.
|
Roberts, R. J., and D. Macelis.
1998.
REBASE-restriction enzymes and methylases.
Nucleic Acids Res.
26:338-350[Abstract/Free Full Text].
|
| 26.
|
Saleh, M.,
L. Selleri,
P. F. Little, and G. A. Evans.
1992.
Isolation and expression of linked zinc finger gene clusters on human chromosome 11q.
Genomics
14:970-978[CrossRef][Medline].
|
| 27.
|
Sethmann, S.,
P. Ceglowski,
J. Willert,
R. Iwanicka-Nowicka,
T. A. Trautner, and J. Walter.
1999.
M.( )BssHII, a novel cytosine-C5-DNA-methyltransferase with target-recognizing domains at separated locations of the enzyme.
EMBO J.
18:3502-3508[CrossRef][Medline].
|
| 28.
|
Stankevicius, K.,
A. Lubys,
A. Timinskas,
D. Vaitkevicius, and A. Janulaitis.
1998.
Cloning and analysis of the four genes coding for Bpu10I restriction-modification enzymes.
Nucleic Acids Res.
26:1084-1091[Abstract/Free Full Text].
|
| 29.
|
Szybalski, W.,
S. C. Kim,
N. Hasan, and A. J. Podhajska.
1991.
Class-IIS restriction enzymes a review.
Gene
100:13-26[CrossRef][Medline].
|
| 30.
|
Wilson, G.
1991.
Organization of restriction-modification systems.
Nucleic Acids Res.
19:2539-2566[Abstract/Free Full Text].
|
| 31.
|
Wilson, G. G., and N. E. Murray.
1991.
Restriction and modification systems.
Annu. Rev. Genet.
25:585-627[CrossRef][Medline].
|
| 32.
|
Winkler, F. K.,
D. W. Banner,
D. Tsernoglou,
R. S. Brown,
S. P. Heathman,
R. K. Bryan,
P. D. Martin,
K. Petratos, and K. S. Wilson.
1993.
The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragments.
EMBO J.
12:1781-1795[Medline].
|
| 33.
|
Xu, S.-Y., and I. Schildkraut.
1991.
Isolation of BamHI variants with reduced cleavage activities.
J. Biol. Chem.
206:4425-4429.
|
Journal of Bacteriology, February 2000, p. 949-955, Vol. 182, No. 4
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mruk, I., Kaczorowski, T.
(2007). A Rapid and Efficient Method for Cloning Genes of Type II Restriction-Modification Systems by Use of a Killer Plasmid. Appl. Environ. Microbiol.
73: 4286-4293
[Abstract]
[Full Text]
-
Haroche, J., Allignet, J., El Solh, N.
(2002). Tn5406, a New Staphylococcal Transposon Conferring Resistance to Streptogramin A and Related Compounds Including Dalfopristin. Antimicrob. Agents Chemother.
46: 2337-2343
[Abstract]
[Full Text]
-
Pingoud, A., Jeltsch, A.
(2001). Structure and function of type II restriction endonucleases. Nucleic Acids Res
29: 3705-3727
[Abstract]
[Full Text]